264 related articles for article (PubMed ID: 30825182)
1. Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer.
Geessink OGF; Baidoshvili A; Klaase JM; Ehteshami Bejnordi B; Litjens GJS; van Pelt GW; Mesker WE; Nagtegaal ID; Ciompi F; van der Laak JAWM
Cell Oncol (Dordr); 2019 Jun; 42(3):331-341. PubMed ID: 30825182
[TBL] [Abstract][Full Text] [Related]
2. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer.
Zhao K; Li Z; Yao S; Wang Y; Wu X; Xu Z; Wu L; Huang Y; Liang C; Liu Z
EBioMedicine; 2020 Nov; 61():103054. PubMed ID: 33039706
[TBL] [Abstract][Full Text] [Related]
3. Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor-stroma ratio in colon cancer.
Polack M; Smit MA; van Pelt GW; Roodvoets AGH; Meershoek-Klein Kranenbarg E; Putter H; Gelderblom H; Crobach ASLP; Terpstra V; Petrushevska G; Gašljević G; Kjær-Frifeldt S; de Cuba EMV; Bulkmans NWJ; Vink GR; Al Dieri R; Tollenaar RAEM; van Krieken JHJM; Mesker WE;
ESMO Open; 2024 Apr; 9(4):102988. PubMed ID: 38613913
[TBL] [Abstract][Full Text] [Related]
4. Digital image analysis provides robust tissue microenvironment-based prognosticators in patients with stage I-IV colorectal cancer.
Jakab A; Patai ÁV; Micsik T
Hum Pathol; 2022 Oct; 128():141-151. PubMed ID: 35820451
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the tumor-stroma ratio in gallbladder cancer.
Li H; Yuan SL; Han ZZ; Huang J; Cui L; Jiang CQ; Zhang Y
Neoplasma; 2017; 64(4):588-593. PubMed ID: 28485165
[TBL] [Abstract][Full Text] [Related]
6. Tumor-stroma ratio is an independent predictor for survival in NSCLC.
Zhang T; Xu J; Shen H; Dong W; Ni Y; Du J
Int J Clin Exp Pathol; 2015; 8(9):11348-55. PubMed ID: 26617859
[TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of tumor-stroma ratio in patients with early stage cervical adenocarcinoma treated by surgery.
Pongsuvareeyakul T; Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Intaraphet S; Siriaunkgul S
Asian Pac J Cancer Prev; 2015; 16(10):4363-8. PubMed ID: 26028100
[TBL] [Abstract][Full Text] [Related]
8. Tumor-stroma ratio is an independent predictor for survival in esophageal squamous cell carcinoma.
Wang K; Ma W; Wang J; Yu L; Zhang X; Wang Z; Tan B; Wang N; Bai B; Yang S; Liu H; Zhu S; Cheng Y
J Thorac Oncol; 2012 Sep; 7(9):1457-61. PubMed ID: 22843085
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor-stroma ratio and a newly developed computer-aided quantitative analysis of routine H&E slides in high-grade serous ovarian cancer.
van Wagensveld L; Walker C; Hahn K; Sanders J; Kruitwagen R; van der Aa M; Sonke G; Rottenberg S; Van de Vijver K; Janowczyk A; Horlings H
Res Sq; 2023 Nov; ():. PubMed ID: 38014112
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancer.
Vangangelt KMH; Green AR; Heemskerk IMF; Cohen D; van Pelt GW; Sobral-Leite M; Schmidt MK; Putter H; Rakha EA; Tollenaar RAEM; Mesker WE
Int J Cancer; 2020 Apr; 146(8):2296-2304. PubMed ID: 31901133
[TBL] [Abstract][Full Text] [Related]
11. Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis.
Wu J; Liang C; Chen M; Su W
Oncotarget; 2016 Oct; 7(42):68954-68965. PubMed ID: 27661111
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of tumor-stroma ratio in tumor-positive axillary lymph nodes of breast cancer patients.
Vangangelt KMH; Tollenaar LSA; van Pelt GW; de Kruijf EM; Dekker TJA; Kuppen PJK; Tollenaar RAEM; Mesker WE
Int J Cancer; 2018 Dec; 143(12):3194-3200. PubMed ID: 29978463
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
14. The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study.
Liang Y; Zhu Y; Lin H; Zhang S; Li S; Huang Y; Liu C; Qu J; Liang C; Zhao K; Li Z; Liu Z
BMC Cancer; 2021 Jun; 21(1):729. PubMed ID: 34172021
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content - a short report.
Sandberg TP; Sweere I; van Pelt GW; Putter H; Vermeulen L; Kuppen PJ; Tollenaar RAEM; Mesker WE
Cell Oncol (Dordr); 2019 Jun; 42(3):397-403. PubMed ID: 30847807
[TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
17. Tumor-stroma ratio is an independent predictor for survival in early cervical carcinoma.
Liu J; Liu J; Li J; Chen Y; Guan X; Wu X; Hao C; Sun Y; Wang Y; Wang X
Gynecol Oncol; 2014 Jan; 132(1):81-6. PubMed ID: 24219981
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer.
Zheng Q; Jiang Z; Ni X; Yang S; Jiao P; Wu J; Xiong L; Yuan J; Wang J; Jian J; Wang L; Yang R; Chen Z; Liu X
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769068
[TBL] [Abstract][Full Text] [Related]
19. Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.
Scheer R; Baidoshvili A; Zoidze S; Elferink MAG; Berkel AEM; Klaase JM; van Diest PJ
World J Gastrointest Oncol; 2017 Dec; 9(12):466-474. PubMed ID: 29290917
[TBL] [Abstract][Full Text] [Related]
20. Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer.
Yan D; Ju X; Luo B; Guan F; He H; Yan H; Yuan J
BMC Cancer; 2022 Oct; 22(1):1082. PubMed ID: 36271354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
